Author:
Joseph Andrew M,Karas Monica,Joubran Ernesto,Ramadan Yaseen O,Fowler Blakley A
Publisher
Springer Science and Business Media LLC
Reference13 articles.
1. COVID-19 vaccination in pregnancy, paediatrics, immunocompromised patients, and persons with history of allergy or prior SARS-CoV-2 infection: overview of current recommendations and pre- and post-marketing evidence for vaccine efficacy and safety;Luxi N;Drug Saf,2021
2. Hospitalizations of children aged 5-11 years with laboratory-confirmed COVID-19 - COVID-NET, 14 states, March 2020-February 2022;Shi DS;MMWR Morb Mortal Wkly Rep,2022
3. COVID-19 in children and adolescents: characteristics and specificities in immunocompetent and oncohematological patients;Mercolini F;Mediterr J Hematol Infect Dis,2022
4. ACIP evidence to recommendations for use of moderna covid-19 vaccine in children ages 6 months - 5 years and pfizer-bioNTech covid-19 vaccine in children ages 6 months - 4 years under an emergency use authorization. (2022). Accessed. May 4, 2022: http://gov.ezproxylocal.library.nova.edu/vaccines/acip/recs/grade/covid-19-moderna-pfizer-children-vaccine-etr.html.
5. Hospitalization rates and characteristics of children aged <18 years hospitalized with laboratory-confirmed COVID-19 - COVID-NET, 14 states, March 1-July 25, 2020;Kim L;MMWR Morb Mortal Wkly Rep,2020